Delivery Order SPE2DB25D3005-SPE2DB25FQHPT
- Not listed
- The Defense Logistics Agency awarded a $2,271.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of YONSA 125 mg, a prescription medication used in oncology treatment. This non-set-aside contract was awarded on July 28, 2025, with an ultimate completion date of August 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a $4,542.74 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of 120 tablets of Yonsa 125 mg, with performance completion targeted for August 22, 2025. This firm fixed-price contract was awarded without set-aside designation through open competition and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Yonsa is a prescription medication used in oncology treatment, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,542.74 to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120-count supply). The contract is firm fixed price with no set-aside designation and is scheduled for completion by August 15, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,294,927 units of the drug YONSA (125 mg tablets, 120 count). The $2,195.48 firm fixed-price contract has a period of performance through November 2024. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,195.48 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4564731145 - YONSA 125 MG TABLET 120S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, AmerisourceBergen provides a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,271.36 for 120 tablets of YONSA 125 mg on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price, competitively awarded contract required no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for...
- This $4,390.96 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for YONSA 125 MG TABLET 120S, a prescription drug product, with an ultimate completion date of October 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- The Defense Logistics Agency Troop Support Medical awarded a $2,195.48 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561453578 YONSA 125 MG TABLET 120S. The place of performance is Conshohocken, Pennsylvania. The period of performance is from July 10, 2023 through July 31, 2023. No major subcontractors or set aside designations were identified. This delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle to supply...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.36 firm fixed-price delivery order is for the supply of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of June 26, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,271.36 to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg on July 21, 2025, with completion scheduled for August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Yonsa (abiraterone acetate) is a specialized pharmaceutical used in the treatment of prostate cancer, reflecting...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB25FQHPTDelivery Order
The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp for 120 tablets of YONSA 125 mg on August 5, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. YONSA (topotecan) is a chemotherapy medication used in the treatment of certain cancers, reflecting the Defense Logistics Agency's continued procurement of specialized pharmaceutical products to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent success in competitive federal procurements and its role as a prime vendor in the DLA's pharmaceutical supply chain underscore its significance as a key provider for military healthcare support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/5/25 |